Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,044 GBX | -0.10% | -2.11% | +13.62% |
07-05 | AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer | MT |
07-05 | AstraZeneca: cancer treatment approved by the EU | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.62% | 239B | |
+57.44% | 823B | |
-7.00% | 353B | |
+15.28% | 320B | |
+7.15% | 295B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.03% | 167B | |
-2.92% | 159B | |
+2.61% | 123B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer